Unlock stock picks and a broker-level newsfeed that powers Wall Street.
35.61
-1.75
(-4.68%)
At close: April 1 at 4:00:00 PM EDT
35.61
0.00
(0.00%)
After hours: April 1 at 5:17:50 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -1.19 | -1.24 | -5.05 | -5.47 |
| Low Estimate | -1.21 | -1.31 | -5.37 | -6.14 |
| High Estimate | -1.16 | -1.19 | -4.63 | -4.8 |
| Year Ago EPS | -0.64 | -0.6 | -3.3 | -5.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.65 | -0.55 | -0.74 | -1.07 |
| EPS Actual | -0.64 | -0.6 | -0.86 | -1.2 |
| Difference | 0.01 | -0.05 | -0.12 | -0.13 |
| Surprise % | 1.54% | -9.09% | -16.22% | -11.89% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.19 | -1.24 | -5.05 | -5.47 |
| 7 Days Ago | -1.19 | -1.25 | -5.1 | -5.38 |
| 30 Days Ago | -1.1 | -1.15 | -4.06 | -4.76 |
| 60 Days Ago | -1.1 | -1.15 | -4.06 | -4.76 |
| 90 Days Ago | -1.1 | -1.15 | -4.06 | -4.76 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 3 | 2 |
| Down Last 30 Days | -- | -- | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| APGE | -85.98% | -106.76% | -53.14% | -8.22% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Initiated | Citigroup: Buy | 3/13/2025 |
| Reiterates | Guggenheim: Buy to Buy | 2/10/2025 |
| Reiterates | Guggenheim: Buy to Buy | 12/12/2024 |
| Reiterates | Guggenheim: Buy to Buy | 12/3/2024 |
| Maintains | Wedbush: Outperform to Outperform | 12/2/2024 |
| Maintains | Guggenheim: Buy to Buy | 11/27/2024 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
15.30
-5.21%
ACLX Arcellx, Inc.
60.70
-7.47%
ORKA Oruka Therapeutics, Inc.
9.56
-6.82%
CRNX Crinetics Pharmaceuticals, Inc.
30.62
-8.71%
MRUS Merus N.V.
39.60
-5.92%
NUVL Nuvalent, Inc.
68.00
-4.12%
MLTX MoonLake Immunotherapeutics
36.35
-6.96%
EWTX Edgewise Therapeutics, Inc.
20.13
-8.50%
CNTA Centessa Pharmaceuticals plc
13.23
-8.00%
IMVT Immunovant, Inc.
15.20
-11.06%